-
Of the 62,168 study participants, 17.5% individuals fulfilled the diagnosis for the cardiometabolic risk factors clustering (18.1% boys and 16.9% girls), and 8.3% were defined as having the HW phenotype, with 8.2% in boys and 8.5% in girls. A total of 6.6% of the participants were classified as having the HWHtR phenotype (8.0% in boys and 5.2% in girls), 34.3% of the participants had high WHR (32.8% in boys and 40.0% in girls). For different cardiometabolic risk factors, 25.7% had elevated BP, 0.3% had impaired FPG, 12.6% had low HDL, 3.0% had elevated LDL, 26.8% had elevated TG, and 5.4% had hypercholesterolemia. Boys had significantly higher SBP, DBP, and FPG than girls (P < 0.05). Girls had significantly higher TG, LDL, and TC than boys (P < 0.05) (Table 1 and Supplementary Table S1, available in www.besjournal.com).
Variables Total Boy (n = 32,064) Girl (n = 30,104) P N x ± s n x ± s n x ± s Age (years) 62,168 10.80 ± 3.30 32,064 10.72 ± 3.26 30,104 10.94 ± 3.34 < 0.001 BMI (kg/m2) 62,168 18.55 ± 3.75 32,064 18.84 ± 3.92 30,104 18.24 ± 3.54 < 0.001 WC (cm) 61,802 64.75 ± 10.79 31,858 65.85 ± 11.50 29,944 63.59 ± 9.86 < 0.001 Hipline (cm) 61,815 77.18 ± 12.00 31,882 77.07 ± 12.07 29,933 77.30 ± 11.92 0.018 CHRF clustering, n (%) < 2 13,195 82.5 6,675 81.9 6,520 83.1 0.056 ≥ 2 2,800 17.5 1,472 18.1 1,328 16.9 HW, n (%) 0 13,736 91.7 7,050 91.8 6,686 91.5 0.479 1 1,249 8.3 628 8.2 621 8.5 HWHtR, n (%) 0 9,079 93.4 4,587 92.0 4,492 94.8 < 0.001 1 644 6.6 397 8.0 247 5.2 WHR, n (%) 0 40,480 65.7 21,373 67.2 19,107 60.0 < 0.001 1 21,153 34.3 10,410 32.8 10,743 40.0 Note. BMI, body mass index; WC, waist circumference; HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist-to-hip ratio; CHRF clustering, cardiometabolic health risk factors clustering. Table 1. General characteristics of the study population by sex
Comparisons were conducted between the participants with and without the HW, HWHtR, and WHR phenotypes. As the results in Supplementary Tables S2–S4 (available in www.besjournal.com) showed, the participants with the HW, HWHtR or WHR phenotypes had significantly higher levels of LDL, TG, TC, and BP, as well as higher cardiometabolic health risk. Moreover, the participants had lower HDL levels than those without these phenotypes. Additionally, the difference of the level of FPG between the participants with and without those phenotypes was insignificant.
Variables Category non-HW HW P N Freq. (%) N Freq. (%) Sex boy 7,050 51.3 628 50.3 0.479 girl 6,686 48.7 621 49.7 Area rural 4,946 41.7 385 36.4 < 0.001 urban 6,905 58.3 672 63.6 Family income
(CNY)< 5,000 3,756 64.3 357 62.9 0.494 ≥ 5,000 2,086 35.7 211 37.1 BP (mmHg) < P90 10,632 77.4 669 53.6 < 0.001 ≥ P90 3,104 22.6 580 46.4 FPG (mmol/L) < 6.1 13,696 99.7 1,242 99.7 0.739 ≥ 6.1 37 0.3 4 0.3 HDL (mmol/L) ≥ 1.03 12,235 89.1 839 67.2 < 0.001 < 1.03 1,501 10.9 410 32.8 LDL (mmol/L) < 3.37 13,384 97.4 1,159 92.8 < 0.001 ≥ 3.37 352 2.6 90 7.2 TG (mmol/L) < 1.24 10,845 79.0 0 0.0 < 0.001 ≥ 1.24 2,891 21.0 1,249 100.0 TC (mmol/L) < 5.17 13,075 95.2 1,098 87.9 < 0.001 ≥ 5.17 661 4.8 151 12.1 CHRF clustering < 2 11,851 86.3 395 31.6 < 0.001 ≥ 2 1,885 13.7 854 68.4 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; CHRF clustering, cardiometabolic health risk factors clustering; HW, hypertriglyceridemic waist. Table S2. Comparisons of cardiometabolic health risk factors between subjects with and without HW phenotype
Variables Category non-WHR WHR P N Freq. (%) N Freq. (%) Sex boy 21,373 52.8 10,410 49.2 < 0.001 girl 19,107 47.2 10,743 50.8 Area rural 12,756 37.7 6,877 36.9 0.081 urban 21,124 62.3 11,770 63.1 Family income (CNY) < 5,000 10,914 63.5 5,612 63.9 0.494 ≥ 5,000 6,285 36.5 3,172 36.1 BP (mmHg) < P90 27,950 77.1 13,999 69.3 < 0.001 ≥ P90 8,316 22.9 6,206 30.7 FPG (mmol/L) < 6.1 10,166 99.7 5,641 99.7 0.683 ≥ 6.1 27 0.3 17 0.3 HDL (mmol/L) ≥ 1.03 9,131 89.6 4,744 83.8 < 0.001 < 1.03 1,064 10.4 920 16.2 LDL (mmol/L) < 3.37 9,979 97.9 5,408 95.5 < 0.001 ≥ 3.37 216 2.1 256 4.5 TG (mmol/L) < 1.24 7,592 74.5 4,013 70.9 < 0.001 ≥ 1.24 2,602 25.5 1,649 29.1 TC (mmol/L) < 5.17 9,745 95.6 5,254 92.8 < 0.001 ≥ 5.17 450 4.4 410 7.2 CHRF clustering < 2 8,715 85.5 4,372 77.2 < 0.001 ≥ 2 1,479 14.5 1,290 22.8 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; CHRF clustering, cardiometabolic health risk factors clustering; WHR, waist-to-hip ratio. Table S4. Comparisons of cardiometabolic health risk factors between subjects with and without WHR phenotype
Multivariate adjusted ORs (95% CIs) for cardiometabolic health risk factors among the HW, HWHtR, and WHR phenotypes are presented in Table 2. With adjustment of age and sex, and BMI, the risk of cardiometabolic health risk factors in the HW or HWHtR phenotype was significantly higher than those without the phenotype among children (HW: OR = 10.79, 95% CI: 9.28–12.55; HWHtR: OR = 9.21, 95% CI: 7.45–11.39). The risks of low HDL, elevated LDL, elevated TC, and high BP were also significantly higher for children with these phenotypes compared with those for children without the HW, HWHtR or WHR phenotype. After adjusting for age, sex, BMI, area, and family income by multivariate logistic regression, the risk of cardiometabolic health risk factors clustering in the HW phenotype was 11.22-fold higher than that in the non-HW group (OR = 12.22, 95% CI: 9.54–15.67). The risk of cardiometabolic health risk factors clustering in the HWHtR phenotype was also higher that than in the non-HWHtR group (HW: OR = 9.70, 95% CI: 6.93–13.58). Those with the HW phenotype were more likely to have low HDL, elevated LDL, elevated TC, and high BP compared with non-HW group. Additionally, except for LDL and TC, there was no significant difference between the HWHtR and HW phenotypes in the OR of risk factors for cardiometabolic risk factors clustering after adjustment of the covariates. The risk of elevation of LDL with the HWHtR phenotype was significantly higher than that with the HW phenotype (HW: OR = 2.96, 95% CI: 1.84–4.75; HWHtR: OR = 6.87, 95% CI: 3.58–13.19). The OR(95%CI) for risk of elevated TC is 3.89 (95%CI: 2.65-5.73) and 4.94 (95%CI: 2.88-8.47) for HW and HWHtR phenotype, respectively. Compared with children with the HW or HWHtR phenotype, the risk of cardiometabolic risk factors clustering in the WHR phenotype was much lower and insignificant.
Models HW HWHtR WHR OR 95% CI P OR 95% CI P OR 95% CI P Model 1 Elevated TG NA NA NA NA NA NA 0.82 0.75–0.89 < 0.001 Low HDL 2.83 2.42–3.32 < 0.001 2.63 2.13–3.24 < 0.001 1.18 1.05–1.31 0.004 Elevated LDL 2.08 1.55–2.78 < 0.001 3.18 2.13–4.74 < 0.001 1.94 1.59–2.38 < 0.001 Elevated TC 2.58 2.05–3.25 < 0.001 2.85 2.04–3.98 < 0.001 1.64 1.41–1.91 < 0.001 Elevated BP 1.42 1.23–1.63 0.007 1.31 1.08–1.58 0.007 0.92 0.88–0.96 < 0.001 FPG 1.07 0.32–3.53 0.540 0.60 0.12–3.02 0.538 1.14 0.57–2.26 0.720 CHRF clustering 10.79 9.28–12.55 < 0.001 9.21 7.45–11.39 < 0.001 1.05 0.95–1.15 0.350 Model 2 Elevated TG NA NA NA NA NA NA 1.09 0.95–1.25 0.234 Low HDL 2.45 1.88–3.19 < 0.001 2.71 1.93–3.80 < 0.001 1.30 1.08–1.55 0.005 Elevated LDL 2.96 1.84–4.75 < 0.001 6.87 3.58–13.19 < 0.001 1.64 1.15–2.33 < 0.001 Elevated TC 3.89 2.65–5.73 < 0.001 4.94 2.88–8.47 < 0.001 1.51 1.15–1.98 0.003 Elevated BP 1.32 1.06–1.66 0.015 1.08 0.80–1.47 0.614 1.00 0.93–1.07 0.905 FPG 0.98 0.10–9.63 0.990 1.59 0.13–19.23 0.716 1.89 0.64–5.54 0.247 CHRF clustering 12.22 9.54–15.67 < 0.001 9.70 6.93–13.58 < 0.001 1.14 0.97–1.34 0.115 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; CHRF clustering, cardiometabolic health risk factors clustering; HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist-to-hip ratio; NA, data not available. Model 1: adjusted for sex (boy or girl), age (years) and BMI. Model 2: adjusted for variables from model 1, and additionally adjusted by area and family income. Table 2. OR (95% CI) of cardiometabolic health risk factors for the HW, HWHtR, and WHR phenotypes
The results of multivariate logistic regression analysis of cardiometabolic health risk factors of the HW, HWHtR, and WHR phenotypes by sex and age stratified according to model 2 are shown in Supplementary Tables S5–S6 (available in www.besjournal.com) and Figures 1–2. The results after stratification by sex and age were similar to those without stratification. The WHR phenotype had a significantly lower and more insignificant risk of cardiometabolic risk factor aggregation than children with the HW or HWHtR phenotypes.
Figure 1. Forest plot of cardiometabolic health risk factors for HW (A), HWHtR (B), and WHR (C) phenotypes stratified by sex. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; NA, data not available. CHRF clustering: cardiometabolic health risk factors clustering. Model: adjusted for age (years), BMI, area and family income. HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist-to-hip ratio.
Figure 2. Forest plot of cardiometabolic health risk factors for HW (A), HWHtR (B), and WHR (C) phenotypes stratified by age. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; NA, data not available. CHRF clustering: cardiometabolic health risk factors clustering. Model: adjusted for sex, BMI, area and family income. HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist-to-hip ratio.
Models HW HWHtR WHR OR 95% CI P OR 95% CI P OR 95% CI P Boys Model 1 Elevated TG NA NA NA NA NA NA 0.94 0.83−1.07 0.330 Low HDL 2.93 2.35−3.67 < 0.001 3.05 2.32−4.01 < 0.001 1.39 1.19−1.62 < 0.001 Elevated LDL 2.22 1.47−3.35 < 0.001 3.02 1.77−5.15 < 0.001 2.01 1.46−2.75 < 0.001 Elevated TC 2.48 1.78−3.46 < 0.001 2.59 1.67−4.02 < 0.001 1.54 1.22−1.96 < 0.001 Elevated BP 1.46 1.19−1.78 0.007 1.48 1.14−1.91 0.003 0.86 0.81−0.92 < 0.001 FPG NA NA NA NA NA NA 1.15 0.49−2.69 0.752 CHRF clustering 14.11 11.23−17.72 < 0.001 15.19 11.23−20.55 < 0.001 1.15 1.00−1.33 0.053 Model 2 Elevated TG NA NA NA NA NA NA 1.12 0.90−1.41 0.304 Low HDL 2.83 1.94−4.15 < 0.001 3.49 2.22−5.48 < 0.001 1.62 1.24−2.11 < 0.001 Elevated LDL 4.58 2.14−9.80 < 0.001 7.47 2.67−20.91 < 0.001 1.78 0.98−3.26 0.060 Elevated TC 3.38 1.88−6.07 < 0.001 3.97 1.85−8.52 < 0.001 1.33 0.86−2.05 0.197 Elevated BP 1.13 0.81−1.58 0.476 1.20 0.78−1.83 0.407 0.93 0.83−1.03 0.152 FPG NA NA NA NA NA NA 3.06 0.89−10.06 0.077 CHRF clustering 15.28 10.44−22.36 < 0.001 16.18 9.91−26.42 < 0.001 1.31 1.02−1.67 0.034 Girls Model 1 Elevated TG NA NA NA NA NA NA 0.73 0.65−0.82 < 0.001 Low HDL 2.68 2.14−3.36 < 0.001 2.16 1.54−3.02 < 0.001 1.04 0.89−1.21 0.646 Elevated LDL 2.00 1.32−3.04 0.001 3.37 1.86−6.14 < 0.001 1.84 1.41−2.41 < 0.001 Elevated TC 2.82 2.05−3.89 < 0.001 3.11 1.87−5.19 < 0.001 1.66 1.36−2.03 < 0.001 Elevated BP 1.34 1.10−1.64 0.004 1.10 0.81−1.49 0.531 0.96 0.90−1.023 0.205 FPG 2.95 0.70−12.47 0.140 2.18 0.29−16.15 0.447 1.43 0.46−4.47 0.542 CHRF clustering 8.84 7.20−10.85 < 0.001 5.33 3.91−7.26 < 0.001 0.96 0.84−1.09 0.498 Model 2 Elevated TG NA NA NA NA NA NA 1.05 0.88−1.26 0.568 Low HDL 2.10 1.45−3.03 < 0.001 2.07 1.22−3.49 0.007 1.11 0.87−1.42 0.413 Elevated LDL 2.26 1.21−4.22 0.010 6.44 2.74−15.15 < 0.001 1.56 1.01−2.42 0.045 Elevated TC 4.55 2.74−7.57 < 0.001 6.25 2.95−13.25 < 0.001 1.64 1.16−2.31 0.005 Elevated BP 1.46 1.07−1.98 0.017 0.98 0.78−1.23 0.858 1.03 0.94−1.14 0.506 FPG 1.43 0.11−19.29 0.786 1.63 0.22−11.96 0.631 0.78 0.12−5.28 0.799 CHRF clustering 10.26 7.38−14.27 < 0.001 5.76 3.57−9.29 < 0.001 1.02 0.83−1.27 0.825 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low−density lipoprotein; TG, triglyceride; TC, total cholesterol. CHRF clustering, cardiometabolic health risk factors clustering; HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist−to−hip ratio; NA, data not available. Model 1: adjusted for age (years) and BMI. Model 2: adjusted for variables from model 1, and additionally adjusted by area and family income. Table S5. OR (95% CI) of cardiometabolic health risk factors for HW, HWHtR and WHR phenotype stratified by sex
-
The study protocol was approved by the Medical Ethical Committee of Peking University (Number: IRB0000105213034). Informed consent was obtained from all participants and their parents involved in the study.
-
Variables Total Boy (n = 32,064) Girl (n = 30,104) P N x ± s (%) n x ± s (%) n x ± s (%) Height 62,168 145.86 ± 17.08 32,064 146.93 ± 18.44 30,104 144.72 ± 15.43 < 0.001 Weight 62,168 40.97 ± 15.53 32,064 42.35 ± 16.88 30,104 39.50 ± 13.79 < 0.001 SBP (mmHg) 62,168 104.33 ± 12.17 32,064 105.72 ± 12.5 30,104 102.85 ± 11.62 < 0.001 DBP (mmHg) 62,168 66.27 ± 8.84 32,064 66.8 ± 8.98 30,104 65.71 ± 8.64 < 0.001 TG (mmol/L) 15,995 1.14 ± 0.81 8,147 1.09 ± 0.80 7,848 1.19 ± 0.83 < 0.001 HDL (mmol/L) 15,998 1.89 ± 1.35 8,149 1.90 ± 1.38 7,849 1.88 ± 1.31 0.476 LDL (mmol/L) 15,998 1.97 ± 0.71 8,149 1.94 ± 0.70 7,849 1.99 ± 0.72 < 0.001 TC (mmol/L) 15,998 3.86 ± 0.90 8,149 3.81 ± 0.90 7,849 3.92 ± 0.90 < 0.001 FPG (mmol/L) 15,990 4.14 ± 1.28 8,143 4.19 ± 1.31 7,847 4.09 ± 1.25 < 0.001 Area rural 19,753 37.3 10,158 37.5 9,595 37.1 0.359 urban 33,221 62.7 16,947 62.5 16,274 62.9 Family income < 5,000 16,646 63.6 8,234 63.0 8,412 64.2 0.042 (CNY) ≥ 5,000 9529 36.4 4,838 37.0 4,691 35.8 BP (mmHg) < P90 42,292 74.3 20,716 70.6 21,576 78.2 < 0.001 ≥ P90 14,642 25.7 8,611 29.4 6,031 21.8 FPG (mmol/L) < 6.1 15,945 99.7 8,111 99.6 7,834 99.8 0.007 ≥ 6.1 45 0.3 32 0.4 13 0.2 HDL (mmol/L) ≥ 1.03 13,987 87.4 7,035 86.3 6,952 88.6 < 0.001 < 1.03 2,011 12.6 1,114 13.7 897 11.4 LDL (mmol/L) < 3.37 15,520 97.0 7,928 97.3 7,592 96.7 0.037 ≥ 3.37 478 3.0 221 2.7 257 3.3 TG (mmol/L) < 1.24 11,702 73.2 6,149 75.5 5,553 70.8 < 0.001 ≥ 1.24 4,293 26.8 1,998 24.5 2,295 29.2 TC (mmol/L) < 5.17 15,128 94.6 7,745 95.0 7,383 94.1 < 0.001 ≥ 5.17 870 5.4 404 5.0 466 5.9 Note. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist-to-height ratio; WHR, waist-to-hip ratio; CHRF clustering, cardiometabolic health risk factors clustering. Table S1. General characteristics of the study population by sex
Variables Category non-HWHtR HWHtR P N Freq. (%) N Freq. (%) Sex boy 4,587 50.5 397 61.6 < 0.001 girl 4,492 49.5 247 38.4 Area rural 3,232 41.0 214 36.7 0.041 urban 4,646 59.0 369 63.3 Family income (CNY) < 5,000 2,534 65.4 182 64.3 < 0.001 ≥ 5,000 1,338 34.6 101 35.7 BP (mmHg) < P90 6,654 73.3 289 44.9 < 0.004 ≥ P90 2,425 26.7 355 55.1 FPG (mmol/L) < 6.1 9,051 99.7 639 99.7 0.907 ≥ 6.1 26 0.3 2 0.3 HDL (mmol/L) ≥ 1.03 7,857 86.5 398 61.8 < 0.001 < 1.03 1,222 13.5 246 38.2 LDL (mmol/L) < 3.37 8,883 97.8 586 91.0 < 0.001 ≥ 3.37 196 2.2 58 9.0 TG (mmol/L) < 1.24 6,617 72.9 0 0.0 < 0.001 ≥ 1.24 2,462 27.1 644 100.0 TC (mmol/L) < 5.17 8,700 95.8 567 88.0 < 0.001 ≥ 5.17 379 4.2 77 12.0 CHRF clustering < 2 7,481 82.4 165 25.6 < 0.001 ≥ 2 1,598 17.6 479 74.4 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; CHRF clustering, cardiometabolic health risk factors clustering; HWHtR, hypertriglyceridemic waist-to-height ratio. Table S3. Comparisons of cardiometabolic health risk factors between subjects with and without HWHtR phenotype
Models HW HWHtR WHR OR 95% CI P OR 95% CI P OR 95% CI P 6–9 years Model 1 Elevated TG NA NA NA NA NA NA 0.70 0.59–0.82 < 0.001 Low HDL 2.97 2.14–4.14 < 0.001 NA NA NA 1.45 1.18–1.78 < 0.001 Elevated LDL 1.38 0.81–2.34 0.233 NA NA NA 1.94 1.44–2.62 < 0.001 Elevated TC 2.08 1.40–3.07 < 0.001 NA NA NA 1.48 1.17–1.86 0.001 Elevated BP 1.54 1.16–2.04 0.003 NA NA NA 0.97 0.89–1.05 0.428 FPG 3.11 0.28–34.78 0.356 NA NA NA 1.81 0.58–5.65 0.310 CHRF clustering 10.04 7.53–13.38 < 0.001 NA NA NA 1.38 1.15–1.66 0.001 Model 2 Elevated TG NA NA NA NA NA NA 1.10 0.83–1.47 0.508 Low HDL 3.23 1.79–5.85 < 0.001 NA NA NA 1.43 1.00–2.04 0.052 Elevated LDL 1.73 0.70–4.28 0.236 NA NA NA 1.49 0.86–2.57 0.155 Elevated TC 2.88 1.42–5.82 0.003 NA NA NA 1.31 0.87–1.98 0.192 Elevated BP 1.40 0.86–2.28 0.172 NA NA NA 1.17 1.03–1.34 0.017 FPG NA NA NA NA NA NA 0.94 0.10–8.86 0.955 CHRF clustering 11.77 7.13−19.44 < 0.001 NA NA NA 1.33 0.96–1.85 0.091 10–12 years Model 1 Elevated TG NA NA NA NA NA NA 0.63 0.54−0.73 < 0.001 Low HDL 3.11 2.32−4.16 < 0.001 3.28 2.37−4.55 < 0.001 1.17 0.93−1.46 0.174 Elevated LDL 2.83 1.73−4.62 < 0.001 3.82 2.25−6.50 < 0.001 2.07 1.42−3.02 < 0.001 Elevated TC 2.91 1.94−4.38 < 0.001 3.56 2.28−5.56 < 0.001 1.83 1.37−2.44 < 0.001 Elevated BP 1.54 1.20−1.98 0.001 1.51 1.14−2.01 0.004 0.87 0.79−0.94 0.001 FPG 1.10 0.11−11.32 0.937 NA NA NA 1.59 0.51−4.96 0.428 CHRF clustering 13.00 9.81−17.22 < 0.001 12.36 8.98−17.03 < 0.001 0.01 0.68−0.97 0.022 Model 2 Elevated TG NA NA NA NA NA NA 0.81 0.64−1.04 0.104 Low HDL 2.85 1.78−4.57 < 0.001 3.50 2.08−5.88 < 0.001 1.57 1.09−2.26 0.016 Elevated LDL 3.71 1.69−8.18 0.001 5.87 2.45−14.02 < 0.001 1.70 0.89−3.25 0.110 Elevated TC 3.37 1.74−6.52 < 0.001 4.84 2.34−10.01 < 0.001 1.87 1.10−3.18 0.021 Elevated BP 1.59 1.07−2.36 0.022 1.12 0.71−1.76 0.634 0.86 0.75−0.99 0.037 FPG NA NA NA NA NA NA 9.05 0.95−85.90 0.055 CHRF clustering 16.73 10.54−26.55 < 0.001 12.69 7.61−21.16 < 0.001 0.96 0.71−1.29 0.776 13−15 years Model 1 Elevated TG NA NA NA NA NA NA 0.88 0.75−1.03 0.109 Low HDL 2.55 1.92−3.38 < 0.001 2.19 1.55−3.10 < 0.001 1.03 0.85−1.25 0.746 Elevated LDL 1.48 0.73−3.01 0.275 1.95 0.86−4.40 0.109 1.28 0.75−2.18 0.361 Elevated TC 2.64 1.58−4.41 < 0.001 1.57 0.80−3.09 0.195 1.57 1.09−2.26 0.016 Elevated BP 1.30 0.99−1.69 0.057 1.47 1.05−2.05 0.025 0.90 0.83−0.98 0.019 FPG NA NA NA NA NA NA 0.31 0.05−2.04 0.222 CHRF clustering 10.06 7.55−13.39 < 0.001 8.07 5.62−11.58 < 0.001 0.86 0.72−1.03 0.095 Model 2 Elevated TG NA NA NA NA NA NA 1.22 0.94−1.57 0.132 Low HDL 1.72 1.08−2.75 0.023 2.29 1.31−4.01 0.004 1.10 0.80−1.51 0.550 Elevated LDL 2.04 0.66−6.35 0.217 4.14 1.07−16.08 0.040 2.46 0.99−6.07 0.052 Elevated TC 5.64 2.45−12.99 < 0.001 3.01 1.02−8.85 0.045 1.94 1.00−3.77 0.050 Elevated BP 1.06 0.69−1.62 0.789 1.03 0.61−1.77 0.903 0.97 0.84−1.11 0.628 FPG NA NA NA NA NA NA NA NA NA CHRF clustering 9.79 6.21−15.44 < 0.001 8.17 4.60−14.53 < 0.001 1.07 0.80−1.42 0.654 16−17 years Model 1 Elevated TG NA NA NA NA NA NA 0.98 0.77−1.24 0.839 Low HDL 2.57 1.76−3.75 < 0.001 2.52 1.61−3.93 < 0.001 1.22 0.91−1.63 0.184 Elevated LDL 4.50 1.97−10.28 < 0.001 3.83 1.48−9.92 0.006 1.81 0.82−3.97 0.140 Elevated TC 4.26 2.17−8.38 < 0.001 4.01 1.79−9.00 0.001 1.37 0.76−2.44 0.295 Elevated BP 1.20 0.84−1.73 0.322 0.94 0.60−1.45 0.768 0.95 0.83−1.08 0.428 FPG 1.39 0.16−11.81 0.763 1.85 0.19−18.26 0.601 0.59 0.06−5.64 0.644 CHRF clustering 10.02 6.79−14.78 < 0.001 8.77 5.45−14.11 < 0.001 1.23 0.94−1.61 0.124 Model 2 Elevated TG NA NA NA NA NA NA 0.93 0.63−1.38 0.712 Low HDL 2.56 1.36−4.81 0.004 2.48 1.19−5.14 0.012 1.32 0.80−2.16 0.275 Elevated LDL 8.62 2.17−34.23 0.002 20.95 4.12−106.44 < 0.001 0.70 0.19−2.64 0.597 Elevated TC 7.85 2.45−25.12 0.001 12.90 3.26−51.15 < 0.001 0.83 0.29−2.35 0.723 Elevated BP 1.25 0.70−2.23 0.453 1.34 0.67−2.68 0.408 0.96 0.78−1.19 0.694 FPG 2.56 0.11−60.52 0.561 3.24 0.11−96.18 0.497 NA NA NA CHRF clustering 12.22 6.48−23.04 < 0.001 11.23 5.31−23.76 < 0.001 1.15 0.74−1.81 0.533 Note. BP, blood pressure; FPG, fasting plasma glucose; HDL, high−density lipoprotein; LDL, low−density lipoprotein; TG, triglyceride; TC, total cholesterol; CHRF clustering, cardiometabolic health risk factors clustering; HW, hypertriglyceridemic waist; HWHtR, hypertriglyceridemic waist−to−height ratio; WHR, waist−to−hip ratio. Model 1: adjusted for sex (boy or girl) and BMI. Model 2: adjusted for variables from model 1, and additionally adjusted by area and family income. Table S6. OR (95% CI) of cardiometabolic health risk factors for HW, HWHtR and WHR phenotype stratified by age
HTML
23144+Supplementary Materials.pdf |